Search results for: 'application delivery'

13 Jan 2021  |  North America  |  Market Research

Technological Advancements and Emerging Applications in the Global Magnetic Resonance Imaging (MRI) Market, Forecast to 2024

Customers’ Unmet Needs and New Technical Applications to Create Opportunities in the MRI Market

Infographics

×

This research service presents an analysis of the global magnetic imaging resonance (MRI) market. It is an in-depth analysis of the current trends, market size, revenue forecast, market penetration, market attractiveness, and low-end, mid-range, high-end Tesla MRI, and extremity MRI. The market is broken down into various regions also.--BEGIN PROMO...

5G is expected to have a major impact on the healthcare industry, especially due to the industry's digital transformation (which is being driven by the COVID-19 pandemic). While several application areas exist for the technology, Frost & Sullivan looks at the niche (but important) area of surgery and how 5G may revolutionize this space. Frost & Sul...

14 Jun 2021  |  North America  |  Market Research

Growth Opportunities for MedTech in the Transformation of the US Healthcare Provider Ecosystem

Transformational Growth in the Care Delivery Landscape is Changing Health Systems into Systems of Health

Infographics

×

Healthcare providers are on the verge of reinventing their role in the care delivery process due to various external factors, such as the following: • Unsustainable growth in healthcare spending driving continuous downward pressure and declining operating margins • The emergence of alternative payment models that focus on patient outcome and re...

Virtual healthcare assistants are playing an instrumental role in improving healthcare delivery. They help patients take charge of their health through personalized reminders, symptom tracking, and health monitoring, and offer instant access to care by immediately answering queries and reducing appointment wait times. They support healthcare profes...

The United States is the world’s largest healthcare market, spending over 18% of its GDP on healthcare. Therefore, it is important for healthcare stakeholders to understand how the US healthcare market functions, primarily its insurance system. The US health insurance landscape has seen significant evolution through various legislations, ranging fr...

The global digital health solutions market for behavioral health management is demonstrating steady and sustained growth, driven by rising demand for accessible, scalable mental health services across employers, payers, and health systems. Persistent workforce shortages, increasing prevalence of mental health conditions, and growing recognition of ...

There have been increasing incidences of rare ophthalmic diseases (e.g., retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis) and prevalent diseases (e.g., age-related macular degeneration [AMD], geographic atrophy). While clinicians have used small molecules as the conventional therapeutic modality to manage these diseases, the urg...

23 Jun 2017  |  Global  |  Market Research

Blockchain Technology in Global Healthcare, 2017–2025

Healthcare Industry Assesses Blockchain Potential to Optimize Healthcare Workflows and Improve Outcome-based Care Delivery Models

Infographics

×

Blockchain technology, with its ubiquitous security infrastructure for seamless health data exchange, holds potential to eliminate the burden and cost of health data reconciliation and facilitate interoperability. Emerging blockchain systems promise to unlock new economic advantages by disintermediating high-cost gatekeepers and automating transact...

08 Sep 2025  |  Global  |  Market Research

Growth Opportunities in Global Protein and Peptide Therapeutics, Forecast to 2030

Cross-Therapeutic Expansion is Driving Transformational Growth Fueled by Novel Formats and Smarter Delivery

Infographics

×

The protein and peptide therapeutics industry is undergoing a profound transformation, driven by next-generation biologics, including multi-specific antibodies, antibody-drug conjugates (ADCs), and GLP-1 treatments. These advances are intensifying competition, while the patent expiries of blockbuster antibodies are accelerating the entry of biosimi...